Dolutegravir

Published November 04, 2012
Susa Coffey, MD
http://hivinsite.ucsf.edu/InSite?page=ar-07-03
Selected Reference
3. Feinberg J, Clotet B, Khuong MA, et al. Once-daily dolutegravir (DTG) is superior to darunavir/ ritonavir (DRV/r) in antiretroviral naive adults: 48 week results from FLAMINGO (ING114915). In: Program and abstracts of the 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy; September 10-13, 2013; Denver. Abstract H-1464a.